Multidrug-Resistant Tuberculosis

Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.

Also Known As:

Drug-Resistant Tuberculosis; Multi-Drug Resistant Tuberculosis; Tuberculosis, Multi-Drug Resistant; Tuberculosis, Multidrug Resistant; Tuberculosis, Multidrug-Resistant; Tuberculosis, MDR; MDR Tuberculosis; Tuberculosis, Drug Resistant; Tuberculosis, Multi Drug Resistant; Tuberculosis, Drug-Resistant

Infections: 526564
- Bacterial Infections and Mycoses: 1
  - Bacterial Infections: 24368
    - Gram-Positive Bacterial Infections: 348
      - Actinomycetales Infections: 1
        Mycobacterium Infections: 93
        Tuberculosis: 48666
        Multidrug-Resistant Tuberculosis: 2430

A Jafarov Selected Research

A Jafarov Research Topics

Disease

Drug/Important Bio-Agent (IBA)